Recombinant ILDR2 (Bapotulimab Biosimilar) antibody

Catalog No. ABIN7597534

The Human Monoclonal anti-ILDR2 (Bapotulimab Biosimilar) antibody has been validated for . It is suitable to detect ILDR2 (Bapotulimab Biosimilar) in samples from Human.

Quick Overview for Recombinant ILDR2 (Bapotulimab Biosimilar) antibody (ABIN7597534)

Target: ILDR2 (Bapotulimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This ILDR2 (Bapotulimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-ILDR2 (Bapotulimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Bapotulimab Biosimilar Antibody

Specificity: Immunoglobulin-like domain-containing receptor 2, ILDR2, C1orf32

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for ILDR2 (Bapotulimab Biosimilar)

Target: ILDR2 (Bapotulimab Biosimilar)

Alternative Name: Bapotulimab Biosimilar

Target Type: Biosimilar

Background: Immunoglobulin-like domain-containing receptor 2, ILDR2, C1orf32

UniProt: Q71H61

CAS-No: 2359413-58-2